Cardiovascular Benefits of Statins Outweigh Low Risk for Muscle Symptoms
TUESDAY, Aug. 30, 2022 (HealthDay News) — Statin therapy appears to cause only a small excess risk for muscle symptoms, according to a study published online Aug. 27 in The Lancet to coincide with the European Society of Cardiology Congress 2022, h…
Learn MoreBiggest Study Yet Finds No Link Between Statins, Muscle Aches
MONDAY, Aug. 29, 2022 (HealthDay News) — Cholesterol-lowering statins are proven lifesavers, but they’ve also gained a reputation for causing muscle aches and pains in a good number of patients.That reputation is undeserved, according to a new large-…
Learn MoreGuidance Developed for Addressing Use of Nonstatin Therapies
MONDAY, Aug. 29, 2022 (HealthDay News) — Several new nonstatin agents have low-density lipoprotein cholesterol-lowering efficacy and can be considered for patients at risk for atherosclerotic cardiovascular disease (ASCVD), according to an expert c…
Learn MoreUSPSTF Recommends Statins for Primary Prevention of CVD in Adults
WEDNESDAY, Aug. 24, 2022 (HealthDay News) — The U.S. Preventive Services Task Force (USPSTF) concludes that people aged 40 to 75 years at high risk for cardiovascular disease (CVD) should receive statins. This finding forms the basis of a final recom…
Learn MoreReal-World Data Links Rosuvastatin to Adverse Effects on Kidneys
THURSDAY, Aug. 18, 2022 (HealthDay News) — Rosuvastatin is associated with increased risks for hematuria, proteinuria, and kidney failure with replacement therapy (KFRT) compared with atorvastatin use, according to a study published online July 19 in…
Learn More